Status: Recruiting
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
The study is designed to describe the different approaches of systemic therapies for the treatment of Cutaneous T-cell Lymphoma in real world setting.
Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fondazione Italiana Linfomi - ETSUpdated: Dec 2, 2025Locations: 18
Eligibility criteria
Confirmed diagnosis of CTCL according to the EORTC 2017 update criteria1. [+4]
Patients not meeting the above-mentioned inclusion criteria. [+1]